Contact

All Stories

  1. Effect of SGLT2 inhibitors on anemia and their possible clinical implications

    Article • Nefrología (English Edition), April 2024, Elsevier

    MD, PhD Aleix Cases

  2. Efecto de los inhibidores del cotransportador sodio-glucosa tipo 2 sobre la anemia: posibles implicaciones clínicas

    Article • Nefrología, March 2024, Elsevier

    MD, PhD Aleix Cases

  3. Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations

    Article • Clinical Kidney Journal, December 2023, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  4. The ERA Registry Annual Report 2021: a summary

    Article • Clinical Kidney Journal, November 2023, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  5. Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N

    Article • Nefrología (English Edition), September 2023, Elsevier

    MD, PhD Aleix Cases

  6. Reticulocyte hemoglobin content and iron therapy in chronic kidney disease: Reply of the Anemia group of the Spanish Society of Nephrology

    Article • Nefrología (English Edition), September 2023, Elsevier

    MD, PhD Aleix Cases

  7. Epidemiology and treatment of renal anaemia in Spain: RIKAS retrospective study

    Article • Nefrología (English Edition), September 2023, Elsevier

    MD, PhD Aleix Cases

  8. Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist

    Article • Nefrología (English Edition), July 2023, Elsevier

    MD, PhD Aleix Cases

  9. Opportunities to improve the management of anemia in peritoneal dialysis patients: lessons from a national study in routine clinical practice

    Article • Clinical Kidney Journal, June 2023, Oxford University Press (OUP)

    Haridian Sosa, MD, PhD Aleix Cases

  10. Agonistas del receptor de péptido similar al glucagón tipo 1 (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo

    Article • Nefrología, August 2022, Elsevier

    MD, PhD Aleix Cases

  11. Impacto pronóstico de la enfermedad renal crónica sobre el cierre percutáneo de la orejuela izquierda en la fibrilación auricular: una experiencia unicéntrica

    Article • Nefrología, May 2022, Elsevier

    MD, PhD Aleix Cases

  12. Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis

    Article • JAMA Network Open, April 2022, American Medical Association (AMA)

    MD, PhD Aleix Cases

  13. Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients

    Article • Journal of Nephrology, February 2022, Springer Science + Business Media

    MD, PhD Aleix Cases

  14. Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient

    Article • American Journal of Nephrology, January 2022, Karger Publishers

    MD, PhD Aleix Cases

  15. Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2021, New England Journal of Medicine (NEJM/MMS)

    MD, PhD Aleix Cases

  16. Iron Deficiency in CKD Without Concomitant Anemia

    Article • Kidney International Reports, November 2021, Elsevier

    MD, PhD Aleix Cases

  17. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

    Article • Kidney Medicine, July 2021, Elsevier

    MD, PhD Aleix Cases

  18. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

    Article • Kidney International, June 2021, Elsevier

    MD, PhD Aleix Cases

  19. Aplastic crisis secondary to parvovirus B19 primoinfection as an infrequent cause of anemia in an immunocompetent, non-dialysis chronic kidney disease patient

    Article • Clinical Nephrology, April 2021, Dustri-Verlgag Dr. Karl Feistle

    MD, PhD Aleix Cases

  20. Medical Director Practice of Advising Increased Dietary Protein Intake in Hemodialysis Patients With Hyperphosphatemia: Associations With Mortality in the Dialysis Outcomes and Practice Patterns Study

    Article • Journal of Renal Nutrition, April 2021, Elsevier

    MD, PhD Aleix Cases, Dr Hirotaka Komaba

  21. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents

    Article • Frontiers in Medicine, March 2021, Frontiers

    MD, PhD Aleix Cases

  22. Ferroterapia en el manejo de la anemia en la enfermedad renal crónica no en diálisis: perspectiva del grupo de anemia de la S.E.N

    Article • Nefrología, March 2021, Elsevier

    MD, PhD Aleix Cases

  23. Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group

    Article • Nefrología (English Edition), March 2021, Elsevier

    MD, PhD Aleix Cases

  24. Effect of comorbidities on survival in patients >80 years of age at onset of renal replacement therapy: data from the ERA-EDTA Registry

    Article • Nephrology Dialysis Transplantation, February 2021, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  25. Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and Mortality

    Article • Kidney International Reports, January 2021, Elsevier

    MD, PhD Aleix Cases

  26. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results

    Article • Blood Purification, December 2020, Karger Publishers

    Diana Rodríguez, MD, PhD Aleix Cases

  27. Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study

    Article • Clinical Kidney Journal, October 2020, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  28. Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia

    Article • Cardiovascular Drugs and Therapy, July 2020, Springer Science + Business Media

    MD, PhD Aleix Cases

  29. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease

    Article • Toxins, June 2020, MDPI AG

    MD, PhD Aleix Cases

  30. Data from the ERA-EDTA Registry was examined for trends in excess mortality in European adults on kidney replacement therapy.

    Article • Kidney International, June 2020, Elsevier

    MD, PhD Aleix Cases

  31. Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide

    Article • Journal of Cellular and Molecular Medicine, November 2019, Wiley

    MD, PhD Aleix Cases

  32. Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry

    Article • Nephrology Dialysis Transplantation, November 2019, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  33. Percutaneous Left Atrial Appendage Closure, A Safe Alternative To Anticoagulation For Patients With Non‐Valvular Atrial Fibrillation And End‐Stage Renal Disease On Hemodialysis: A Single Center Experience

    Article • Artificial Organs, November 2019, Wiley

    MD, PhD Aleix Cases

  34. Sex Differences in Kidney Replacement Therapy Initiation and Maintenance

    Article • Clinical Journal of the American Society of Nephrology, October 2019, American Society of Nephrology

    MD, PhD Aleix Cases

  35. Changes in clinical indicators related to the transition from dialysis to kidney transplantation—data from the ERA-EDTA Registry

    Article • Clinical Kidney Journal, July 2019, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  36. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider

    Article • Nutrients, June 2019, MDPI AG

    MD, PhD Aleix Cases

  37. Mortality due to bleeding, myocardial infarction and stroke in dialysis patients

    Article • Journal of Thrombosis and Haemostasis, August 2018, Wiley

    Dr Runolfur Palsson, MD, PhD Aleix Cases

  38. ¿Son seguros y eficaces los antiagregantes plaquetarios en los pacientes con insuficiencia renal?

    Article • Cardiocore, April 2018, Elsevier

    MD, PhD Aleix Cases

  39. Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe—data from the ERA-EDTA Registry

    Article • Nephrology Dialysis Transplantation, January 2018, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  40. Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease

    Article • Cellular Physiology and Biochemistry, January 2018, Karger Publishers

    MD, PhD Aleix Cases

  41. Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology

    Article • Nefrología (English Edition), January 2018, Elsevier

    MD, PhD Aleix Cases

  42. Anemia en la enfermedad renal crónica: protocolo de estudio, manejo y derivación a Nefrología

    Article • Atención Primaria, January 2018, Elsevier

    MD, PhD Aleix Cases

  43. Anemia en la enfermedad renal crónica: protocolo de estudio, manejo y derivación a Nefrología

    Article • Nefrología, January 2018, Elsevier

    MD, PhD Aleix Cases

  44. Anemia en la enfermedad renal crónica: protocolo de estudio, manejo y derivación a Nefrología

    Article • Medicina de Familia SEMERGEN, January 2018, Elsevier

    MD, PhD Aleix Cases

  45. Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia

    Article • Drugs of Today, January 2018, Prous Science

    MD, PhD Aleix Cases

  46. Prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease

    Article • Drugs of the Future, January 2018, Prous Science

    MD, PhD Aleix Cases

  47. Insuficiencia cardíaca en la enfermedad renal y déficit de hierro: importancia de la ferroterapia

    Article • Nefrología, November 2017, Elsevier

    MD, PhD Aleix Cases

  48. Heart failure in patients with kidney disease and iron deficiency: The role of iron therapy

    Article • Nefrología (English Edition), November 2017, Elsevier

    MD, PhD Aleix Cases

  49. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function

    Article • BMC Nephrology, September 2017, Springer Science + Business Media

    MD, PhD Aleix Cases

  50. TO021DIRECT FACTOR Xa INHIBITOR APIXABAN PREVENTS ENDOTHELIAL ACTIVATION AND DAMAGE ASSOCIATED WITH CHRONIC KIDNEY DISEASE

    Article • Nephrology Dialysis Transplantation, May 2017, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  51. Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis

    Article • BMC Nephrology, February 2017, Springer Science + Business Media

    MD, PhD Aleix Cases

  52. Gut microbiota in chronic kidney disease

    Article • Nefrología (English Edition), January 2017, Elsevier

    MD, PhD Aleix Cases

  53. Enfermedad renal crónica y dislipidemia

    Article • Clínica e Investigación en Arteriosclerosis, January 2017, Elsevier

    MD, PhD Aleix Cases

  54. Microbiota intestinal en la enfermedad renal crónica

    Article • Nefrología, January 2017, Elsevier

    MD, PhD Aleix Cases

  55. Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study

    Article • American Journal of Cardiovascular Drugs, November 2016, Springer Science + Business Media

    MD, PhD Aleix Cases

  56. Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study

    Article • Nefrología (English Edition), November 2016, Elsevier

    MD, PhD Aleix Cases

  57. Consenso Delphi sobre el diagnóstico y manejo de la dislipidemia en pacientes con enfermedad renal crónica: análisis post-hoc del estudio DIANA

    Article • Nefrología, November 2016, Elsevier

    MD, PhD Aleix Cases

  58. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study

    Article • Nephrology Dialysis Transplantation, May 2016, Oxford University Press (OUP)

    Dr Jose M Valdivielso, MD, PhD Aleix Cases

  59. Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteración del metabolismo de la glucosa: estudio Diana

    Article • Clínica e Investigación en Arteriosclerosis, May 2016, Elsevier

    MD, PhD Aleix Cases

  60. Estudio EPRICS con eritropoyetina: otro intento fallido para evitar el daño renal poscirugía cardiaca

    Article • Cirugía Cardiovascular, March 2016, Elsevier

    MD, PhD Aleix Cases

  61. WITHDRAWN: Estudio EPRICS con eritropoyetina: otro intento fallido para evitar el daño renal poscirugía cardiaca

    Article • Cirugía Cardiovascular, December 2015, Elsevier

    MD, PhD Aleix Cases

  62. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

    Article • Circulation, July 2015, Wolters Kluwer Health

    MD, PhD Aleix Cases

  63. Carotid Atherosclerotic Disease Predicts Cardiovascular Events in Hemodialysis Patients: A Prospective Study

    Article • PLoS ONE, June 2015, PLOS

    MD, PhD Aleix Cases

  64. FO020ENDOTHELIAL DYSFUNCTION IN UREMIA: EFFECT OF FLAVONOIDS AND ANTIOXIDANTS

    Article • Nephrology Dialysis Transplantation, May 2015, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  65. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Article • Nephrology Dialysis Transplantation, March 2015, Oxford University Press (OUP)

    prof alberto ortiz , Dr Jose M Valdivielso, MD, PhD Aleix Cases

  66. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1

    Article • Nefrología (English Edition), March 2015, Elsevier

    Prof Alberto M Martínez-Castelao, MD, PhD Aleix Cases

  67. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1

    Article • Nefrología, March 2015, Elsevier

    Prof Alberto M Martínez-Castelao, MD, PhD Aleix Cases

  68. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

    Article • Clinical Journal of the American Society of Nephrology, February 2015, American Society of Nephrology

    Dr Geoffrey A Block, Dr Tilman B. Drueke, Ricardo Correa-Rotter, Dr Gerard M LONDON, Jürgen Floege, MD, PhD Aleix Cases

  69. TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia

    Article • European Journal of Clinical Investigation, January 2015, Wiley

    MD, PhD Aleix Cases

  70. Efficacy of a Simple Dosage Scheme to Convert From Shorter-acting Erythropoiesis-stimulating Agent to Continuous Erythropoietin Receptor Activator in Kidney Transplantation Patients

    Article • Transplantation Proceedings, January 2015, Elsevier

    MD, PhD Aleix Cases

  71. Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study

    Article • International Urology and Nephrology, August 2014, Springer Science + Business Media

    MD, PhD Aleix Cases

  72. Sensitivity of Blood Volume Monitoring for Fluid Status Assessment in Hemodialysis Patients

    Article • Blood Purification, January 2013, Karger Publishers

    MD, PhD Aleix Cases

  73. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia

    Article • Nephrology Dialysis Transplantation, November 2012, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  74. NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach

    Article • PLoS ONE, August 2012, PLOS

    MD, PhD Aleix Cases

  75. Relación del grado de control glucémico con las características de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES

    Article • Medicina Clínica, May 2012, Elsevier

    MD, PhD Aleix Cases

  76. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study

    Article • BMC Nephrology, October 2011, Springer Science + Business Media

    MD, PhD Aleix Cases

  77. Nocturnal, every-other-day, online haemodiafiltration: an effective therapeutic alternative

    Article • Nephrology Dialysis Transplantation, September 2011, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  78. Respuesta

    Article • Revista Española de Cardiología, August 2010, Elsevier

    MD, PhD Aleix Cases

  79. Prevalence of Chronic Kidney Disease in Patients With or at a High Risk of Cardiovascular Disease

    Article • Revista Española de Cardiología (English Edition), February 2010, Elsevier

    MD, PhD Aleix Cases

  80. Prevalencia de insuficiencia renal crónica en pacientes de alto riesgo o con enfermedad cardiovascular

    Article • Revista Española de Cardiología, February 2010, Elsevier

    MD, PhD Aleix Cases

  81. Response

    Article • Revista Española de Cardiología (English Edition), January 2010, Elsevier

    MD, PhD Aleix Cases

  82. What Infusion Flow Should Be Used for Mid-Dilution Hemodiafiltration?

    Article • Blood Purification, January 2010, Karger Publishers

    MD, PhD Aleix Cases

  83. Introducción

    Article • Medicina Clínica, June 2009, Elsevier

    Professor Philippe Gabriel STEG, MD, PhD Aleix Cases

  84. Abordaje multidisciplinar de la enfermedad aterotrombótica

    Article • Medicina Clínica, June 2009, Elsevier

    MD, PhD Aleix Cases

  85. Conclusiones

    Article • Medicina Clínica, May 2009, Elsevier

    MD, PhD Aleix Cases

  86. Mid-Dilution Hemodiafiltration: A Comparison with Pre- and Postdilution Modes Using the Same Polyphenylene Membrane

    Article • Blood Purification, January 2009, Karger Publishers

    MD, PhD Aleix Cases

  87. Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study

    Article • Kidney International, December 2008, Elsevier

    MD, PhD Aleix Cases

  88. In Vivo Evaluation of Platelet Activation by Different Cellulosic Membranes

    Article • Artificial Organs, November 2008, Wiley

    MD, PhD Aleix Cases

  89. Prevalence and Clinical Characteristics of HIV Type 1-Infected Patients Receiving Dialysis in Spain: Results of a Spanish Survey in 2006: GESIDA 48/05 Study

    Article • AIDS Research and Human Retroviruses, October 2008, Mary Ann Liebert Inc

    MD, PhD Aleix Cases

  90. Influence of the Ionic Dialysance Monitor on Kt Measurement in Hemodialysis

    Article • American Journal of Kidney Diseases, July 2008, Elsevier

    MD, PhD Aleix Cases

  91. Mspl identifies a biallelic polymorphism in the promoter region of the α2A-adrenergic receptor gene

    Article • Clinical Genetics, June 2008, Wiley

    MD, PhD Aleix Cases

  92. Differential Expression of Proteins From Cultured Endothelial Cells Exposed to Uremic Versus Normal Serum

    Article • American Journal of Kidney Diseases, April 2008, Elsevier

    MD, PhD Aleix Cases

  93. Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents

    Article • Clinical Nephrology, February 2008, Dustri-Verlgag Dr. Karl Feistle

    MD, PhD Aleix Cases

  94. Effect of Two Different Dialysis Membranes on Leukocyte Adhesion and Aggregation

    Article • Nephron Clinical Practice, March 2007, Karger Publishers

    MD, PhD Aleix Cases

  95. Dyslipidemia and the progression of renal disease in chronic renal failure patients

    Article • Kidney International, December 2005, Elsevier

    MD, PhD Aleix Cases

  96. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study

    Article • Nephrology Dialysis Transplantation, November 2005, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  97. Cigarette smoke concentrate increases 8-epi-PGF2$alpha; and TGF$beta;1 secretion in rat mesangial cells

    Article • Life Sciences, June 2004, Elsevier

    MD, PhD Aleix Cases

  98. The effects of smoking and its cessation on 8-epi-PGF2α and transforming growth factor-beta 1 in Type 1 diabetes mellitus

    Article • Diabetic Medicine, January 2004, Wiley

    MD, PhD Aleix Cases

  99. Biocompatibility of Cellulosic and Synthetic Membranes Assessed by Leukocyte Activation

    Article • American Journal of Nephrology, January 2004, Karger Publishers

    MD, PhD Aleix Cases

  100. Update in nephrology: Highlights from the 36th Annual Meeting of the ASN

    Article • Drugs of Today, January 2004, Prous Science

    MD, PhD Aleix Cases

  101. Interactions Between Vasoconstrictors and Vasodilators in Regulating Hemodynamics of Distinct Vascular Beds

    Article • Hypertension, October 2003, Wolters Kluwer Health

    MD, PhD Aleix Cases

  102. Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture

    Article • Nephrology Dialysis Transplantation, June 2003, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  103. Darbepoetin alfa: A novel erythropoiesis-stimulating protein

    Article • Drugs of Today, January 2003, Prous Science

    MD, PhD Aleix Cases

  104. Nonconvulsive status epilepticus in dialysis patients

    Article • American Journal of Kidney Diseases, February 2002, Elsevier

    MD, PhD Aleix Cases

  105. Morbimortalidad cardiovascular en la diabetes mellitus tipo 2

    Article • Hipertensión y Riesgo Vascular, January 2002, Elsevier

    MD, PhD Aleix Cases

  106. Análisis de la frecuencia cardíaca como factor de riesgo asociado a la progresión de la insuficiencia renal crónica

    Article • Medicina Clínica, January 2002, Elsevier

    MD, PhD Aleix Cases

  107. Erythropoietin Triggers a Signaling Pathway in Endothelial Cells and Increases the Thrombogenicity of their Extracellular Matrices In Vitro

    Article • Thrombosis and Haemostasis, January 2002, Thieme Publishing Group

    MD, PhD Aleix Cases

  108. Effect of angiotensin II receptor blockade on renal disease progression in patients with non‐diabetic chronic renal failure

    Article • Nephrology Dialysis Transplantation, May 2001, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  109. Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs

    Article • AJP Regulatory Integrative and Comparative Physiology, January 2001, American Physiological Society

    MD, PhD Aleix Cases

  110. Hipermineralocorticismo exógeno como causa de descompensación de una hipertensión esencial previamente controlada

    Article • Hipertensión y Riesgo Vascular, January 2001, Elsevier

    MD, PhD Aleix Cases

  111. Mecanismos de desarrollo del daño vascular en pacientes en diálisis

    Article • Hipertensión y Riesgo Vascular, January 2001, Elsevier

    MD, PhD Aleix Cases

  112. Uremic Medium Disturbs the Hemostatic Balance of Cultured Human Endothelial Cells

    Article • Thrombosis and Haemostasis, January 2001, Thieme Publishing Group

    MD, PhD Aleix Cases

  113. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension

    Article • Kidney International, October 2000, Elsevier

    MD, PhD Aleix Cases

  114. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling

    Article • Kidney International, May 2000, Elsevier

    MD, PhD Aleix Cases

  115. Papel de la adrenomedulina en el control de la presión arterial y la homeostasis del líquido extracelular

    Article • Hipertensión y Riesgo Vascular, January 2000, Elsevier

    MD, PhD Aleix Cases

  116. Doxazosin in a gastrointestinal therapeutic system formulation

    Article • Drugs of Today, January 2000, Prous Science

    MD, PhD Aleix Cases

  117. Novel Erythropoiesis Stimulating Protein

    Article • Drugs of the Future, January 2000, Prous Science

    MD, PhD Aleix Cases

  118. Recombinant human erythropoietin treatment in chronic renal failure: Effects on hemostasis and vasculature

    Article • Drugs of Today, January 2000, Prous Science

    MD, PhD Aleix Cases

  119. β-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives

    Article • Journal of Human Hypertension, January 2000, Springer Science + Business Media

    MD, PhD Aleix Cases

  120. Smoking increases serum levels of transforming growth factor-beta in diabetic patients

    Article • Diabetes Care, November 1999, American Diabetes Association

    MD, PhD Aleix Cases

  121. Clinical pharmacology of nebivolol

    Article • Drugs of Today, January 1999, Prous Science

    MD, PhD Aleix Cases

  122. Erythropoietin Improves Signaling through Tyrosine Phosphorylation in Platelets from Uremic Patients

    Article • Thrombosis and Haemostasis, January 1999, Thieme Publishing Group

    MD, PhD Aleix Cases

  123. Lamifiban

    Article • Drugs of the Future, January 1999, Prous Science

    MD, PhD Aleix Cases

  124. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: Association with early improvement in platelet function

    Article • American Journal of Hematology, October 1998, Wiley

    MD, PhD Aleix Cases

  125. Renal Failure in Multiple Myeloma

    Article • Archives of Internal Medicine, September 1998, American Medical Association (AMA)

    MD, PhD Aleix Cases

  126. Platelet-Leukocyte Activation during Hemodialysis Detected with a Monoclonal Antibody to Leukocyte Integrin CD11b

    Article • January 1998, Karger Publishers

    MD, PhD Aleix Cases

  127. Advances in hypertension management: Update 1998

    Article • Drugs of Today, January 1998, Prous Science

    MD, PhD Aleix Cases

  128. Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients

    Article • Nephrology Dialysis Transplantation, May 1997, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  129. New Insights Into the Pathophysiology of Renovascular Hypertension

    Article • Mayo Clinic Proceedings, March 1997, Elsevier

    MD, PhD Aleix Cases

  130. Vasoactive hormones in uraemic patients with chronic hypotension

    Article • Nephrology Dialysis Transplantation, February 1997, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  131. Correspondence

    Article • American Journal of Hypertension, July 1996, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  132. Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

    Article • British Journal of Haematology, December 1995, Wiley

    MD, PhD Aleix Cases

  133. Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix

    Article • Nephrology Dialysis Transplantation, December 1995, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  134. Reticulated platelets in uremic patients: Effect of hemodialysis and continuous ambulatory peritoneal dialysis

    Article • American Journal of Hematology, November 1995, Wiley

    MD, PhD Aleix Cases

  135. Effect of antihypertensive treatment on the increased β-adrenoceptor density in patients with essential hypertension

    Article • American Journal of Hypertension, May 1995, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  136. Reversible Decrease of Surface ß2-Adrenoceptor Number and Response in Lymphocytes of Patients with Pheochromocytoma

    Article • Clinical and Experimental Hypertension, January 1995, Taylor & Francis

    MD, PhD Aleix Cases

  137. 24 Effect of antihypertensive treatment on increased (??2-adrenoceptor density in patients with essential hypertension

    Article • Journal of Hypertension, December 1993, Wolters Kluwer Health

    MD, PhD Aleix Cases

  138. 31 Decreased ??2-adrenoceptor number and responsiveness in patients with phaeochromocytoma

    Article • Journal of Hypertension, December 1993, Wolters Kluwer Health

    MD, PhD Aleix Cases

  139. Intracellular calcium mobilization and activation of the Na+/H+exchanger in platelets

    Article • Biochemical Journal, March 1993, Portland Press Ltd.

    MD, PhD Aleix Cases

  140. Minimal-Change Glomerulopathy and Carcinoma

    Article • American Journal of Nephrology, January 1993, Karger Publishers

    MD, PhD Aleix Cases

  141. Recombinant human erythropoietin treatment improves platelet function in uremic patients

    Article • Kidney International, September 1992, Elsevier

    MD, PhD Aleix Cases

  142. Calciphylaxis in a Hemodialysis Patient: Appearance After Parathyroidectomy During a Psoriatic Flare

    Article • American Journal of Kidney Diseases, March 1992, Elsevier

    MD, PhD Aleix Cases

  143. Lymphocyte surface beta2-adrenoceptors in essential hypertension

    Article • Journal of Hypertension, December 1991, Wolters Kluwer Health

    MD, PhD Aleix Cases

  144. Lymphocyte surface beta2-adrenoceptors in essential hypertension

    Article • Journal of Hypertension, January 1991, Wolters Kluwer Health

    MD, PhD Aleix Cases

  145. Tumor Markers in Chronic Renal Failure and Hemodialysis Patients

    Article • January 1991, Karger Publishers

    MD, PhD Aleix Cases

  146. Ocular and Auditory Toxicity in Hemodialyzed Patients Receiving Desferrioxamine

    Article • January 1990, Karger Publishers

    MD, PhD Aleix Cases

  147. Lymphocyte β2-Adrenergic Receptors in Essential Hypertension: Studies in Basal Conditions and After Dynamic Exercise

    Article • Clinical and Experimental Hypertension Part A Theory and Practice, January 1989, Taylor & Francis

    MD, PhD Aleix Cases

  148. Treatment of Hyperkalaemia in Renal Failure: Salbutamol v. Insulin

    Article • Nephrology Dialysis Transplantation, January 1989, Oxford University Press (OUP)

    MD, PhD Aleix Cases

  149. Improvement of renal function in azotaemic hypertensive patients after surgical revascularization

    Article • BJS, June 1988, Wiley

    MD, PhD Aleix Cases

  150. Reversal of Renal Failure after Revascularization in Atheromatous Renovascular Disease

    Article • American Journal of Nephrology, January 1988, Karger Publishers

    MD, PhD Aleix Cases

  151. A Possible Pathogenic Mechanism for Rhabdomyolysis Associated with Multiple Myeloma

    Article • Acta Haematologica, January 1987, Karger Publishers

    MD, PhD Aleix Cases

  152. Visceral Involvement of Dialysis Amyloidosis

    Article • American Journal of Nephrology, January 1987, Karger Publishers

    MD, PhD Aleix Cases

  153. Rhabdomyolysis Associated With Pleural Tuberculosis

    Article • Archives of Internal Medicine, December 1986, American Medical Association (AMA)

    MD, PhD Aleix Cases

  154. NIFEDIPINE-INDUCED PAROTITIS

    Article • The Lancet, August 1986, Elsevier

    MD, PhD Aleix Cases